LynxCare logo — Unlocking Clinical Outcomes & Real-World Evidence at scale....

LynxCare

Unlocking Clinical Outcomes & Real-World Evidence at scale. Discover the Power of Precision Medical Data.

Founded 2016 Belgium Belgium 35 employees Series A Total: $24.45M AI, Health Care

General Information

Company Name LynxCare
Founded Year 2016
Location Belgium Belgium
Employees 35
Industries AI, Health Care
Funding Stage Series A
Business Model B2B, SaaS, DaaS
Revenue Model Subscription, Usage Based, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with LynxCare. To contact LynxCare, visit lynx.care.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

AI Insight

Bounce Watch AI
2 months ago

LynxCare's current recruitment for a single position, planned for June 2026, indicates a highly selective and potentially strategic talent acquisition. This forward-looking hiring suggests a methodical approach to strengthening a specific functional area rather than broad expansion. It signals an intent to bolster their capabilities within the complex Real-World Data and Clinical NLP domain.

Signal Types
Hiring
Strategic Labels
Targeted Hiring Specialized Talent Methodical Growth
Next Move: Expansion
·
Impact: 3/10
·
Ideal For: HealthTech Growth Investors — Series B

About LynxCare

LynxCare, founded in 2016, is a pioneering company headquartered in Belgium, operating at the intersection of AI and Health Care. Their mission, encapsulated by the slogan "Unlocking Clinical Outcomes & Real-World Evidence at scale," underscores their focus on precision medical data. The company leverages EHR-derived insights from a federated hospital network to provide high-quality, validated, and cNLP-enriched medical data.

Utilizing a secure European infrastructure, LynxCare aims to offer real-world medical data that stakeholders across the healthcare sector can trust. The company recently secured a €20.00M Series A investment on 21 June 2022 from a consortium of investors, including Elaia, Matterwave Ventures, MTIP, PMV, b2venture, and HERAN Partners. These funds signal strong investor confidence, reinforcing the company's potential to revolutionize the medical data landscape through its innovative AI solutions.

Taxonomy: EHR-derived insights, Federated hospital network, cNLP-enriched medical data, Clinical Data Warehouse, Natural Language Processing, Text Mining, Patient Empowerment, OMOP, Interoperability, Real-World Evidence, Life sciences research, AI-powered Big Data platform, Clinical efficiency improvement

Services & Products

Federated Analytics
Clinical NLP-enriched Medical Data
Quality Assurance Processes
Multi-Country EHR Data Access
Data Extraction and Enrichment

Target Customers

Healthcare Researchers Pharmaceutical Companies Regulatory Bodies Clinical Data Scientists

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Series A €20.00M 6
Elaia, Matterwave Ventures +4
21 Jun 2022
Seed Round €1.80M 3
Alchemist Accelerator, Matterwave Ventures +1
29 Jan 2020
Seed Round €1.75M 2
ING Belgium, Annie Vereecken
08 Apr 2019
Debt Financing €500.00K 2
PMV, Agentschap Innoveren & Ondernemen
13 Oct 2017
Angel Round €290.00K -
15 Dec 2016
Pre Seed Round €110.00K 2
Caring Entrepreneurship Fund, iMinds Ventures
01 Mar 2016

LynxCare Alternatives & Competitors

View All Alternatives
LynxCare vs

Unlocking power of clinical data.

Seed
15 employees
AI, Analytics
LynxCare vs
IOMED
IOMED Spain

Empowering Healthcare Data

Series A
57 employees
AI, Health Care
LynxCare vs
OKRA.ai
OKRA.ai United Kingdom

AI analytics for healthcare, providing real-time evidence-based insights and predictions to empower...

Seed
16 employees
AI, Analytics

FAQ About LynxCare

Unlocking Clinical Outcomes & Real-World Evidence at scale. Discover the Power of Precision Medical Data.
LynxCare was founded in 2016.
LynxCare is headquartered in Belgium.
LynxCare operates in AI and Health Care. Its work centres on EHR-derived insights, Federated hospital network, cNLP-enriched medical data and Clinical Data Warehouse. Its customers include Healthcare Researchers, Pharmaceutical Companies and Regulatory Bodies.
LynxCare has a B2B, SaaS and DaaS business model. Its revenue comes from Subscription, Usage Based and Service Fee.
LynxCare has approximately 35 employees.
LynxCare has completed 6 funding rounds, raising a total of $24.45M. The latest funding stage is Series A.
LynxCare offers: Federated Analytics, Clinical NLP-enriched Medical Data, Quality Assurance Processes, Multi-Country EHR Data Access, Data Extraction and Enrichment.
Top alternatives and competitors to LynxCare include CliniNote - unlocking clinical data, IOMED, OKRA.ai, xCures, HEALWELL AI (TSX: AIDX). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
LynxCare and CliniNote - unlocking clinical data are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for LynxCare, https://bouncewatch.com/company/lynxcare, updated 7 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes